Sarepta Therapeutics (SRPT) option IV movement

Sarepta Therapeutics (NASDAQ: SRPT) 30-day option implied volatility is at 71; compared to its 52-week range of 39 to 144 amid the FDA informed Sarepta that it requires modest additional time to complete the review for Biologics License Application for SRP-9001, including final label negotiations and post marketing commitment discussions, and that it anticipates that the review will be complete by June 22.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1 call to 1 put into quarter results
• Varonis Systems (VRNS) call put ratio 4.4 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 6.4%
• Western Digital (WDC) call put ratio 1 call to 1.2 puts into Micron (MU) quarter results